Raymond James & Associates’s Abbott ABT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $385M | Buy |
3,372,735
+220,777
| +7% | +$24.2M | 0.23% | 76 |
|
|
2024
Q2 | $328M | Sell |
3,151,958
-1,951
| -0.1% | -$207K | 0.22% | 81 |
|
|
2024
Q1 | $358M | Buy |
3,153,909
+91,118
| +3% | +$10.4M | 0.24% | 72 |
|
|
2023
Q4 | $337M | Sell |
3,062,791
-9,843
| -0.3% | -$983K | 0.25% | 68 |
|
|
2023
Q3 | $298M | Buy |
3,072,634
+70,355
| +2% | +$7.39M | 0.25% | 69 |
|
|
2023
Q2 | $327M | Buy |
3,002,279
+8,422
| +0.3% | +$898K | 0.27% | 66 |
|
|
2023
Q1 | $303M | Sell |
2,993,857
-106,911
| -3% | -$11.3M | 0.26% | 71 |
|
|
2022
Q4 | $340M | Sell |
3,100,768
-66,761
| -2% | -$6.91M | 0.31% | 58 |
|
|
2022
Q3 | $306M | Buy |
3,167,529
+235,291
| +8% | +$25.1M | 0.31% | 59 |
|
|
2022
Q2 | $319M | Sell |
2,932,238
-94,390
| -3% | -$10.7M | 0.31% | 62 |
|
|
2022
Q1 | $358M | Buy |
3,026,628
+26,024
| +0.9% | +$3.23M | 0.3% | 62 |
|
|
2021
Q4 | $422M | Buy |
3,000,604
+145,210
| +5% | +$18.6M | 0.34% | 55 |
|
|
2021
Q3 | $337M | Buy |
2,855,394
+104,337
| +4% | +$12.8M | 0.3% | 59 |
|
|
2021
Q2 | $319M | Buy |
2,751,057
+119,158
| +5% | +$13.9M | 0.29% | 60 |
|
|
2021
Q1 | $315M | Buy |
2,631,899
+258,210
| +11% | +$30.6M | 0.32% | 56 |
|
|
2020
Q4 | $260M | Buy |
2,373,689
+279,601
| +13% | +$30.4M | 0.29% | 64 |
|
|
2020
Q3 | $228M | Sell |
2,094,088
-11,014
| -0.5% | -$1.12M | 0.28% | 65 |
|
|
2020
Q2 | $192M | Buy |
2,105,102
+60,620
| +3% | +$5.48M | 0.26% | 69 |
|
|
2020
Q1 | $161M | Buy |
2,044,482
+7,240
| +0.4% | +$604K | 0.26% | 68 |
|
|
2019
Q4 | $177M | Buy |
2,037,242
+53,283
| +3% | +$4.46M | 0.22% | 78 |
|
|
2019
Q3 | $166M | Buy |
1,983,959
+50,122
| +3% | +$4.26M | 0.23% | 77 |
|
|
2019
Q2 | $163M | Sell |
1,933,837
-89,312
| -4% | -$7.03M | 0.23% | 78 |
|
|
2019
Q1 | $162M | Sell |
2,023,149
-97,218
| -5% | -$7.23M | 0.25% | 74 |
|
|
2018
Q4 | $153M | Buy |
2,120,367
+33,485
| +2% | +$2.35M | 0.27% | 69 |
|
|
2018
Q3 | $153M | Buy |
2,086,882
+101,959
| +5% | +$6.69M | 0.24% | 81 |
|
|
2018
Q2 | $121M | Buy |
1,984,923
+132,339
| +7% | +$8.02M | 0.2% | 94 |
|
|
2018
Q1 | $111M | Sell |
1,852,584
-82,888
| -4% | -$4.99M | 0.2% | 97 |
|
|
2017
Q4 | $110M | Sell |
1,935,472
-412,249
| -18% | -$22.8M | 0.2% | 96 |
|
|
2017
Q3 | $125M | Buy |
2,347,721
+56,651
| +2% | +$2.84M | 0.25% | 80 |
|
|
2017
Q2 | $111M | Buy |
2,291,070
+226,590
| +11% | +$10.3M | 0.24% | 84 |
|
|
2017
Q1 | $91.7M | Buy |
2,064,480
+274,466
| +15% | +$11.9M | 0.21% | 98 |
|
|
2016
Q4 | $68.8M | Buy |
1,790,014
+1,932
| +0.1% | +$76.6K | 0.18% | 121 |
|
|
2016
Q3 | $75.6M | Buy |
1,788,082
+266,404
| +18% | +$11.4M | 0.21% | 107 |
|
|
2016
Q2 | $59.8M | Buy |
1,521,678
+101,863
| +7% | +$4.05M | 0.19% | 110 |
|
|
2016
Q1 | $59.4M | Sell |
1,419,815
-73,735
| -5% | -$2.92M | 0.2% | 101 |
|
|
2015
Q4 | $67.1M | Buy |
1,493,550
+131,902
| +10% | +$5.82M | 0.24% | 79 |
|
|
2015
Q3 | $54.8M | Sell |
1,361,648
-103,895
| -7% | -$4.9M | 0.22% | 91 |
|
|
2015
Q2 | $71.9M | Buy |
1,465,543
+196,636
| +15% | +$9.44M | 0.28% | 69 |
|
|
2015
Q1 | $58.8M | Buy |
1,268,907
+84,310
| +7% | +$3.87M | 0.26% | 80 |
|
|
2014
Q4 | $53.3M | Buy |
1,184,597
+537,381
| +83% | +$23.4M | 0.26% | 73 |
|
|
2014
Q3 | $26.9M | Buy |
647,216
+31,650
| +5% | +$1.34M | 0.15% | 131 |
|
|
2014
Q2 | $25.2M | Buy |
615,566
+33,076
| +6% | +$1.3M | 0.16% | 127 |
|
|
2014
Q1 | $22.4M | Buy |
582,490
+204,245
| +54% | +$7.87M | 0.15% | 135 |
|
|
2013
Q4 | $14.5M | Buy |
378,245
+21,388
| +6% | +$788K | 0.11% | 203 |
|
|
2013
Q3 | $11.8M | Buy |
356,857
+46,886
| +15% | +$1.65M | 0.1% | 210 |
|
|
2013
Q2 | $10.8M | Buy |
+309,971
| New | +$11.4M | 0.1% | 216 |
|
Other funds holding ABT
Raymond James & Associates's ABT Position: Q3 2024 in Review
Raymond James & Associates increased its Abbott (ABT) stake by 7% in Q3 2024, buying an estimated $24.2M and bringing the position to 3,372,735 shares worth $385M. The position accounts for 0.23% of the portfolio, ranked #76.
Raymond James & Associates first reported a position in ABT in Q2 2013 and has held it in 46 quarters since. The position peaked at $422M in Q4 2021. 2,896 funds tracked by Wall St. Rank hold ABT as of Q3 2024.
- Raymond James & Associates held 3,372,735 shares of Abbott worth $385M as of Q3 2024.
- Raymond James & Associates bought 220,777 Abbott shares in Q3 2024, an estimated $24.2M.
- Abbott made up 0.23% of Raymond James & Associates's portfolio in Q3 2024, its #76 holding.
- Raymond James & Associates first reported a position in Abbott in Q2 2013 and has held it in 46 quarters since.
- Raymond James & Associates's Abbott position peaked at $422M in Q4 2021.
- 2,896 funds tracked by Wall St. Rank held Abbott as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.